Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Batchelor

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Journal of the American Heart Association|January 19, 2026
Paclitaxel-Coated Balloon for Treating In-Stent Restenosis in Racial and Ethnic Minority Patients: A Subanalysis From the AGENT IDE TrialYasser Jamil, Ajay Kirtane, Robert W Yeh, et al.
Circulation|May 15, 2023
Sarcopenia and Cardiovascular DiseasesAbdulla A Damluji, Maha Alfaraidhy, Noora AlHajri, et al.
American Heart Journal|December 27, 2023
Influence of left ventricular ejection fraction in patients undergoing contemporary pLVAD-supported high-risk PCIArsalan Abu-Much, Cindy L Grines, Wayne B Batchelor, et al.
Journal of the American College of Cardiology|April 29, 2026
Aligning Coronary Stent Trial Enrollment With the U.S. Intended-Use Population: Implications of Site SelectionWayne B Batchelor, Robert Califf, Roxana Mehran, et al.
Circulation|September 18, 2002
Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and EptifibatideWayne B Batchelor, Thaddeus R Tolleson, Yao Huang, et al.
Circulation|April 3, 2025
Outcomes of Transcatheter Aortic Valve Replacement in Low-Risk Patients in the United States: A Report From the STS/ACC TVT RegistryAndrew M Vekstein, Zachary K Wegermann, Pratik Manandhar, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 28, 2021
Racial and ethnic disparities in coronary, vascular, structural, and congenital heart diseaseCindy L Grines, Andrew J Klein, Holly Bauser-Heaton, et al.
Journal of the American College of Cardiology|April 19, 2008
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II studyMitchell W Krucoff, Dean J Kereiakes, John L Petersen, et al.
JACC. Advances|October 30, 2025
Percutaneous Coronary Intervention or Medical Therapy for Chronic Total Occlusion in Older AdultsYasser Jamil, Matthew Dermksian, Alaaeddine El Ghazawi, et al.
JAMA Cardiology|December 8, 2022
Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular TherapiesAshwin S Nathan, Kriyana P Reddy, Lin Yang, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Journal of the American Heart Association|January 19, 2026
Paclitaxel-Coated Balloon for Treating In-Stent Restenosis in Racial and Ethnic Minority Patients: A Subanalysis From the AGENT IDE TrialYasser Jamil, Ajay Kirtane, Robert W Yeh, et al.
Circulation|May 15, 2023
Sarcopenia and Cardiovascular DiseasesAbdulla A Damluji, Maha Alfaraidhy, Noora AlHajri, et al.
American Heart Journal|December 27, 2023
Influence of left ventricular ejection fraction in patients undergoing contemporary pLVAD-supported high-risk PCIArsalan Abu-Much, Cindy L Grines, Wayne B Batchelor, et al.
Journal of the American College of Cardiology|April 29, 2026
Aligning Coronary Stent Trial Enrollment With the U.S. Intended-Use Population: Implications of Site SelectionWayne B Batchelor, Robert Califf, Roxana Mehran, et al.
Circulation|September 18, 2002
Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and EptifibatideWayne B Batchelor, Thaddeus R Tolleson, Yao Huang, et al.
Circulation|April 3, 2025
Outcomes of Transcatheter Aortic Valve Replacement in Low-Risk Patients in the United States: A Report From the STS/ACC TVT RegistryAndrew M Vekstein, Zachary K Wegermann, Pratik Manandhar, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 28, 2021
Racial and ethnic disparities in coronary, vascular, structural, and congenital heart diseaseCindy L Grines, Andrew J Klein, Holly Bauser-Heaton, et al.
Journal of the American College of Cardiology|April 19, 2008
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II studyMitchell W Krucoff, Dean J Kereiakes, John L Petersen, et al.
JACC. Advances|October 30, 2025
Percutaneous Coronary Intervention or Medical Therapy for Chronic Total Occlusion in Older AdultsYasser Jamil, Matthew Dermksian, Alaaeddine El Ghazawi, et al.
JAMA Cardiology|December 8, 2022
Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular TherapiesAshwin S Nathan, Kriyana P Reddy, Lin Yang, et al.
Pageof 14